Instant Access to a Merck representative at
your convenience
Merck OnCall works as an adjunct to field-based representatives to provide health care professionals with services and resources, such as:
- Product information updates
- Complimentary samples
- Patient education materials
- Assistance and updates on Merck Web sites
- Access to a medical services pharmacist
| Hours of Operation | |
|---|---|
| Monday | 8 AM – Midnight ET |
| Tuesday | 8 AM – Midnight ET |
| Wednesday | 8 AM – Midnight ET |
| Thursday | 8 AM – Midnight ET |
| Friday | 8 AM – 6 PM ET |
| Saturday | 8 AM – 3 PM ET |
Merck OnCall: Reaching Goals at Merck
Merck OnCall is ready to help you better understand and utilize the many products and services available at Merck.
Our customer support services are designed to accommodate your busy schedule and provide information about Merck products in a timely, accurate fashion. You can contact
Merck OnCall at your convenience and be confident you'll receive the same high caliber of service you'd expect from your local Merck representative.
Within minutes, arrange a
Merck OnCall Web conference with
a live Merck representative.
Get products and services
information from the source:
800-235-1432.
Watch a video tour of Merck OnCall.
Frequently asked questions about Merck OnCall.
SINGULAIR is indicated for relief of symptoms of allergic rhinitis (seasonal allergic rhinitis in adults and children aged 2 years and older and perennial allergic rhinitis in adults and children aged 6 months and older).
SELECTED SAFETY INFORMATION
- Neuropsychiatric events have been reported in patients taking SINGULAIR. These events included agitation, aggressive behavior or hostility, anxiousness, depression, dream abnormalities, hallucinations, insomnia, irritability, restlessness, somnambulism, suicidal thinking and behavior (including suicide), and tremor. The clinical details of some postmarketing reports appear consistent with a drug-induced effect. Patients should be advised to report any neuropsychiatric events.
- In clinical trials in patients with allergic rhinitis, adverse events varied by age. The most commonly reported adverse events, occurring at a frequency of >1% and at an incidence greater than placebo, regardless of causality assessment, were sinusitis, upper respiratory infection, sinus headache, cough, epistaxis, headache, otitis media, pharyngitis, and increased ALT.
- SINGULAIR is contraindicated in patients with hypersensitivity to any component of this product.
Before prescribing SINGULAIR, please read the Prescribing Information.
20951837(3)-02/10-SNG
For general information and other services for physicians
SINGULAIR, Merck OnCall, and MerckServices are registered trademarks of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
PRIVACY POLICY